Financial reports
ARS
2023 FY
Annual report to shareholders
19 Mar 24
10-K
2023 FY
Annual report
9 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
10-Q
2023 Q1
Quarterly report
2 May 23
ARS
2022 FY
Annual report to shareholders
17 Mar 23
10-K
2022 FY
Annual report
10 Feb 23
10-Q
2022 Q3
Quarterly report
1 Nov 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
10-Q
2022 Q1
Quarterly report
3 May 22
Current reports
8-K
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results and Reaffirms 2024 Outlook
6 Feb 24
8-K
Inspire Medical Systems, Inc. Announces Chair Marilyn Carlson Nelson to Retire and Timothy P. Herbert named Chair and Chief Executive Officer
5 Feb 24
8-K
Inspire Medical Systems, Inc. Announces Jerry C. Griffin, M.D. to Retire from its Board after Sixteen Years of Service
26 Jan 24
8-K
Inspire Medical Systems, Inc. Announces Preliminary Results
8 Jan 24
8-K
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Myriam J. Curet, M.D. to its Board of Directors
28 Dec 23
8-K
Regulation FD Disclosure
7 Nov 23
8-K
Inspire Medical Systems, Inc. Announces Third Quarter 2023 Financial Results and Updates 2023 Outlook
7 Nov 23
8-K
Regulation FD Disclosure
1 Aug 23
8-K
Inspire Medical Systems, Inc. Announces Second Quarter 2023 Financial Results and Updates 2023 Outlook
1 Aug 23
8-K
Regulation FD Disclosure
22 May 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
15 Aug 22
424B5
Prospectus supplement for primary offering
11 Aug 22
424B5
Prospectus supplement for primary offering
15 Apr 20
424B5
Prospectus supplement for primary offering
13 Apr 20
S-3ASR
Automatic shelf registration
13 Apr 20
424B4
Prospectus supplement with pricing info
7 Dec 18
S-1
IPO registration
4 Dec 18
DRS
Draft registration statement
21 Nov 18
S-8
Registration of securities for employees
8 May 18
424B4
Prospectus supplement with pricing info
4 May 18
Proxies
DEFA14A
Additional proxy soliciting materials
19 Mar 24
DEF 14A
Definitive proxy
19 Mar 24
DEFA14A
Additional proxy soliciting materials
17 Mar 23
DEF 14A
Definitive proxy
17 Mar 23
DEFA14A
Additional proxy soliciting materials
16 Mar 22
DEF 14A
Definitive proxy
16 Mar 22
DEFA14A
Additional proxy soliciting materials
16 Mar 21
DEF 14A
Definitive proxy
16 Mar 21
DEFR14A
Revised proxy
17 Mar 20
DEFA14A
Additional proxy soliciting materials
16 Mar 20
Other
EFFECT
Notice of effectiveness
7 Dec 18
CORRESP
Correspondence with SEC
4 Dec 18
CORRESP
Correspondence with SEC
4 Dec 18
UPLOAD
Letter from SEC
3 Dec 18
EFFECT
Notice of effectiveness
2 May 18
CORRESP
Correspondence with SEC
30 Apr 18
CORRESP
Correspondence with SEC
30 Apr 18
CERT
Certification of approval for exchange listing
25 Apr 18
CORRESP
Correspondence with SEC
13 Apr 18
UPLOAD
Letter from SEC
13 Mar 18
Ownership
4
Richard Buchholz
18 Apr 24
144
Notice of proposed sale of securities
17 Apr 24
4
Gary Lee Ellis
16 Apr 24
4
Casey M Tansey
16 Apr 24
4
Shelley G. Broader
16 Apr 24
4
Georgia Melenikiotou
16 Apr 24
4
MARILYN C NELSON
16 Apr 24
4/A
Timothy P. Herbert
3 Apr 24
4
Timothy P. Herbert
3 Apr 24
4
Jerry C Griffin
3 Apr 24